Trajan Group Holdings Limited (TRJ.AX)
AUD 1.0
(-3.85%)
AUD 1.0
(-3.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -25.32 Million AUD | -1440.87% |
| 2023 | 1.88 Million AUD | 10.86% |
| 2022 | 1.7 Million AUD | -9.36% |
| 2021 | 1.88 Million AUD | -28.24% |
| 2020 | 2.62 Million AUD | 22.32% |
| 2019 | 2.14 Million AUD | 47.93% |
| 2018 | 1.44 Million AUD | 109.55% |
| 2017 | 691 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -12.47 Million AUD | 0.0% |
| 2024 FY | -25.32 Million AUD | -1440.87% |
| 2024 Q2 | -378 Thousand AUD | -100.0% |
| 2024 Q1 | -189 Thousand AUD | 85.43% |
| 2024 Q3 | -12.47 Million AUD | -3200.4% |
| 2023 Q2 | 3.18 Million AUD | 100.0% |
| 2023 Q1 | 1.59 Million AUD | 2.71% |
| 2023 FY | 1.88 Million AUD | 10.86% |
| 2023 Q4 | -1.29 Million AUD | -100.0% |
| 2023 Q3 | -648.5 Thousand AUD | -120.35% |
| 2022 Q3 | 477.5 Thousand AUD | 212.09% |
| 2022 Q2 | 153 Thousand AUD | 100.0% |
| 2022 Q1 | 76.5 Thousand AUD | 105.64% |
| 2022 FY | 1.7 Million AUD | -9.36% |
| 2022 Q4 | 1.55 Million AUD | 224.82% |
| 2021 Q1 | 1.61 Million AUD | 10.18% |
| 2021 FY | 1.88 Million AUD | -28.24% |
| 2021 Q4 | -1.35 Million AUD | -100.0% |
| 2021 Q3 | -678.5 Thousand AUD | -120.96% |
| 2021 Q2 | 3.23 Million AUD | 100.0% |
| 2020 Q1 | 575.5 Thousand AUD | 0.0% |
| 2020 FY | 2.62 Million AUD | 22.32% |
| 2020 Q4 | 1.46 Million AUD | 101.65% |
| 2020 Q3 | 728.5 Thousand AUD | -36.71% |
| 2020 Q2 | 1.15 Million AUD | 100.0% |
| 2019 FY | 2.14 Million AUD | 47.93% |
| 2018 FY | 1.44 Million AUD | 109.55% |
| 2017 FY | 691 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Austco Healthcare Limited | 7.07 Million AUD | 457.956% |
| Nanosonics Limited | 12.97 Million AUD | 295.259% |
| Osteopore Limited | -4.87 Million AUD | -419.891% |
| SDI Limited | 10.42 Million AUD | 343.057% |